From Our Partners
Saturday, June 25, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Medical Countermeasures

XJTLU Research Indicates No Clinical Benefit for Corticosteroid Treatment of COVID-19

by Global Biodefense Staff
March 13, 2020
The Administration is Setting Up the U.S. to Botch a Pandemic Response

Image Credit: Global Biodefense

A new study led by a Xi’an Jiaotong-Liverpool University (XJTLU) researcher in the wake of the SARS-CoV-2 epidemic indicates that for patients with mild COVID-19, prescribing corticosteroids has no clinical benefit.

The small-sample observational study of 31 patients with mild COVID-19 was conducted in designated hospitals in Wuhu, Anhui province, China, from 24 January to 24 February, with 11 of these patients receiving corticosteroid treatment.

Statistical analysis showed no association between the virus clearance time, length of hospital stay, or duration of symptoms with corticosteroid use.

The researcher, Dr Lei Zha, is a critical care specialist in Wuhu and is undertaking a PhD project on antimicrobial resistant bacteria, supervised by Dr Boris Tefsen (Department of Biological Sciences) and Professor Elmer Villaneuva (Department of Health and Environmental Sciences) at XJTLU.

Dr Zha has led a team of authors that produced this paper on the COVID-19 patients, which the Medical Journal of Australia (MJA) has just highlighted and is publishing.

“We analysed data from patients in Wuhu, and we didn’t find association between corticosteroid use and clinical outcomes in patients with COVID-19, which means no harm, no benefit,” Dr Zha said.

“However, all the patients enrolled in our research had mild disease, so we only can conclude corticosteroids didn’t affect clinical outcomes in COVID-19 patients without ARDS (Acute Respiratory Disease Syndrome). Patients with a combination of COVID-19 and ARDS may benefit from corticosteroids but clinical evidence is still required to support this.”

This research also found that patients with both hepatitis B and COVID-19 were shown to have the virus longer in their bodies than patients with COVID-19 only.  The authors indicated that this finding requires further study.

Laureate Professor Nick Talley, editor-in-chief of the MJA stated that this article of research is one of two articles that are being published pre-print by the journal, and that it would be published in the next available print edition of the MJA.

“To ensure rapid and broad dissemination, the article preprints have been uploaded online to mja.com.au and a commentary has been published in InSight+,” wrote Professor Talley.

“We have also shared the information with the WHO with the authors’ permission.”

From Our Partners
Tags: COVID-19Magazine Edition 24 March 2020SARS-CoV-2

Related Posts

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control
Medical Countermeasures

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Biodefense Industry News
Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022
Monkeypox Cases Prompt Additional Contracts for Bavarian Nordic Vaccine
Medical Countermeasures

Monkeypox Cases Prompt Additional Contracts for Bavarian Nordic Vaccine

May 30, 2022
Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors
Industry News

Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors

May 26, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC